A randomized, evaluator-blinded, vehicle-controlled study to explore the pharmacodynamic effects of omiganan and omiganan in combination with imiquimod in healthy volunteers.

Trial Profile

A randomized, evaluator-blinded, vehicle-controlled study to explore the pharmacodynamic effects of omiganan and omiganan in combination with imiquimod in healthy volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 24 Jul 2017

At a glance

  • Drugs Imiquimod (Primary) ; Imiquimod (Primary) ; Omiganan (Primary) ; Omiganan (Primary)
  • Indications Dermatitis
  • Focus Biomarker; Pharmacodynamics; Therapeutic Use
  • Sponsors Cutanea Life Sciences
  • Most Recent Events

    • 21 May 2017 Status changed from recruiting to completed.
    • 30 Jan 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top